Spotlight Session Sponsors
Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for oncology and immunological diseases, utilizing its two patented fully human transgenic mouse platforms (H2L2 and HCAbs). Harbour BioMed licenses both platforms through its Harbour Antibodies subsidiary.
Associate Director of Business Development and Alliances
Find us at the event
- Stand number